Applications and advancements of nanoparticle-based drug delivery in alleviating lung cancer and chronic obstructive pulmonary disease
Lung cancer (LC) and chronic obstructive pulmonary disease (COPD) are among the
leading causes of mortality worldwide. Cigarette smoking is among the main aetiologic …
leading causes of mortality worldwide. Cigarette smoking is among the main aetiologic …
Antibiotic loaded inhalable liposomal nanoparticles against lower respiratory tract infections: Challenges, recent advances, and future perspectives
VK Panthi, KE Fairfull-Smith, N Islam - Journal of Drug Delivery Science …, 2024 - Elsevier
Lower respiratory tract infections (LRTIs) are inherited disorders which often causes chronic
respiratory infections for which patients repeatedly receive oral antibiotics, particularly …
respiratory infections for which patients repeatedly receive oral antibiotics, particularly …
Precise Antibiotic Delivery to the Lung Infection Microenvironment Boosts the Treatment of Pneumonia with Decreased Gut Dysbiosis
L Fu, S Huo, P Lin, J Wang, J Zhao, Y You, X Nie… - Acta Biomaterialia, 2024 - Elsevier
Bacterial pneumonia is a common disease with significant health risks. However, the
overuse antibiotics in clinics face challenges such as inadequate targeting and limited drug …
overuse antibiotics in clinics face challenges such as inadequate targeting and limited drug …
Ciprofloxacin-Loaded Inhalable Formulations against Lower Respiratory Tract Infections: Challenges, Recent Advances, and Future Perspectives
VK Panthi, KE Fairfull-Smith, N Islam - Pharmaceutics, 2024 - mdpi.com
Inhaled ciprofloxacin (CFX) has been investigated as a treatment for lower respiratory tract
infections (LRTIs) associated with cystic fibrosis (CF), chronic obstructive pulmonary disease …
infections (LRTIs) associated with cystic fibrosis (CF), chronic obstructive pulmonary disease …
Inflammatory-Targeted Lipid Carrier as a New Nanomaterial to Formulate an Inhaled Drug Delivery System
There is a pressing need for efficacious therapies in the field of respiratory diseases and
infections. Lipid nanocarriers, administered through aerosols, represent a promising tool for …
infections. Lipid nanocarriers, administered through aerosols, represent a promising tool for …